We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOS:NYSEMosaic Company (The) Analysis

Data as of 2026-04-18 - not real-time

$24.57

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The Mosaic Company (MOS) is trading at $24.57, below its 20‑day SMA of $25.17, 50‑day SMA of $27.08 and 200‑day SMA of $29.34, signaling a bearish price trend. RSI sits at 43.4 and the MACD histogram is negative, while volume is on a decreasing trajectory, with a near‑term support around $23.06 and resistance near $27.15. Volatility is high at 69% over the past 30 days despite a low beta (~0.54), indicating sharp price swings that are not strongly correlated with the broader market. The DCF‑derived fair value of $15.42 is more than 50% below the current price, suggesting the stock is overvalued, and free cash flow is negative ($‑433 M) amid $5.28 B of debt, raising concerns about the sustainability of the 3.58% dividend (payout ratio ~52%).
Recent headlines show a 7.6% rally on the company's rare‑earth expansion plans, yet a BofA downgrade triggered a 9.96% drop, underscoring the stock’s sensitivity to news. While the dividend yield is attractive, its sustainability is questionable given cash‑flow constraints. Analyst consensus targets around $31 imply upside potential, but technicals remain bearish and sector‑specific regulatory pressures persist, leaving investors to balance high volatility against modest growth prospects.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish technical indicators
  • price trading above DCF fair value
  • decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • rare earth expansion catalyst
  • dividend yield attractiveness
  • analyst price targets

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • long‑term commodity demand
  • low beta reducing market risk
  • diversified geographic footprint

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin4.49%
P/E Ratio14.5
ROE4.82%
ROA2.84%
Debt/Equity43.15
P/B Ratio0.6
Op. Cash Flow$824.8M
Free Cash Flow$-433049984

Technical Analysis

TrendBearish
RSI43.4
Support$23.06
Resistance$27.15
MA 20$25.17
MA 50$27.08
MA 200$29.34
MACDBearish
VolumeDecreasing
Fear & Greed Index90.21

Valuation

Fair Value$15.42
Target Price$30.85
Upside/Downside25.57%
GradeOvervalued
TypeValue
Dividend Yield3.58%

Risk Assessment

Beta0.54
Volatility69.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.